Montecito Bank & Trust Gilead Sciences, Inc. Transaction History

Montecito Bank & Trust

$497 Million
Q1 2024

A detailed history of Montecito Bank & Trust transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Montecito Bank & Trust holds 6,489 shares of GILD stock, worth $432,751. This represents 0.1% of its overall portfolio holdings.

Number of Shares

6,489

Previous 6,589 1.52%

Holding current value

$432,751

Previous $533,000 10.88%

% of portfolio

0.1%

Previous 0.12%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 09, 2024	SELL	$71.58 - $87.29 $7,158 - $8,729	-100 Reduced 1.52%	6,489 $475,000
Q4 2023 Jan 05, 2024	SELL	$73.27 - $83.09 $952 - $1,080	-13 Reduced 0.2%	6,589 $533,000
Q3 2023 Oct 16, 2023	BUY	$73.94 - $80.67 $57,007 - $62,196	771 Added 13.22%	6,602 $494,000
Q2 2023 Jul 25, 2023	BUY	$76.01 - $86.7 $9,349 - $10,664	123 Added 2.15%	5,831 $449,000
Q1 2023 Apr 24, 2023	SELL	$77.31 - $88.08 $3,169 - $3,611	-41 Reduced 0.71%	5,708 $473,000

Q3 2022 Oct 14, 2022	SELL	$59.54 - $68.01 $10,419 - $11,901	-175 Reduced 2.95%	5,749 $355,000
Q2 2022 Aug 01, 2022	SELL	$57.72 - $65.01 $1,731 - $1,950	-30 Reduced 0.5%	5,924 $367,000
Q1 2022 Apr 22, 2022	SELL	$57.92 - $72.58 $33,130 - $41,515	-572 Reduced 8.76%	5,954 $354,000
Q4 2021 Jan 25, 2022	SELL	$64.88 - $73.64 $11,418 - $12,960	-176 Reduced 2.63%	6,526 $474,000
Q3 2021 Oct 28, 2021	BUY	$67.69 - $73.03 $18,750 - $20,229	277 Added 4.31%	6,702 $468,000
Q4 2020 Jan 28, 2021	SELL	$56.65 - $64.55 $100,327 - $114,318	-1,771 Reduced 21.61%	6,425 $375,000
Q2 2020 Jul 17, 2020	BUY	$72.34 - $84.0 $112,705 - $130,872	1,558 Added 23.47%	8,196 $630,000
Q1 2020 Apr 23, 2020	SELL	$62.63 - $80.22 $2,818 - $3,609	-45 Reduced 0.67%	6,638 $497,000
Q4 2019 Jan 22, 2020	SELL	$61.62 - $67.78 $15,651 - $17,216	-254 Reduced 3.66%	6,683 $434,000
Q3 2019 Oct 18, 2019	SELL	$62.51 - $69.0 $1,687 - $1,863	-27 Reduced 0.39%	6,937 $440,000
Q2 2019 Jul 05, 2019	SELL	$61.87 - $69.38 $61 - $69	-1 Reduced 0.01%	6,964 $470,000
Q4 2018 Feb 05, 2019	SELL	$60.54 - $79.0 $52,911 - $69,046	-874 Reduced 11.15%	6,965 $436,000
Q3 2018 Oct 11, 2018	SELL	$71.28 - $78.92 $204,359 - $226,263	-2,867 Reduced 26.78%	7,839 $606,000
Q2 2018 Aug 02, 2018	BUY	$64.88 - $75.68 $53,266 - $62,133	821 Added 8.31%	10,706 $759,000
Q1 2018 Apr 23, 2018	BUY	$72.84 - $88.8 $720,023 - $877,788	9,885 New	9,885 $745,000
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $715,555 - $839,960	-10,057 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $44,326 - $52,032	623 Added 6.6%	10,057 $720,000
Q3 2017 Oct 23, 2017	BUY	$72.11 - $85.47 $680,285 - $806,323	9,434	9,434 $764,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Montecito Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Montecito Bank & Trust with notifications on news.

Account

Montecito Bank & Trust Gilead Sciences, Inc. Transaction History